Australia News
-
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed to the position of Chief Executive Officer. Mr Charles (Charlie) Wa...Read more
-
Doctors now offer GI Dynamic's EndoBarrier Therapy to treat diabetes
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: GI Dynamics announced that doctors at St. Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney now offer EndoBarrier Therapy, a revolutionary, non-surgical, non-ph...Read more
-
What the future holds for the APAC CRO market?
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more
-
Indo-Aussie research to find ovarian cancer cure
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more
-
Changes in PBS to help Aussies save $20 mn
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2013
Singapore: The listings and price changes that came into effect in Australia this August through the Pharmaceutical Benefits Scheme (PBS) is said to see saving of $20 million a year. Furth...Read more
-
Intl anesthesia society appoints board members
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2012
Singapore: SmartTots, a research initiative sponsored by International Anesthesia Research Society, a non-political medical society that supports anesthesia research and education, has appo...Read more
-
Australian firm registers 25 disease specific stem cell lines at NIH
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Australia's Genea Stem Cells, a supplier and developer of disease-specific human stem cells, has been successful in registering 25 of its disease specific embryonic pluripotent s...Read more
-
Trial begins for vaccine that builds gluten tolerance
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical trials to evaluate Nexvax2, the first therapeutic vaccine for patients wi...Read more
-
Adhesive patch to deliver drugs
Australia | News | By Nandita Singh | 0 Comment | 14 Mar, 2012
One of the promising alternative drug delivery technologies is a transdermal delivery platform called targeted pentration matrix (TPM). Australia-based Phosphagenics has been working to dev...Read more
-
CSL Biotherapies awarded Pandemic Preparedness Contract by US Government
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: CSL Biotherapies has been awarded by the United States (US) Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to t...Read more
-
Uscom signs deal to distribute its devices in China
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Oct, 2013
Singapore: Australia-based Uscom (Ultrasonic Cardiac Output Monitor) has gained a foothold into the rapidly growing Chinese medical device market after reaching an agreement with China Pion...Read more
-
Scientists discover childhood epilepsy genes
Australia | News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2013
Singapore: National Institute of Health (NIH)-funded genetic study of childhood epilepsies has linked two new genes to severe forms of disease and provides a novel strategy for identifying ...Read more
-
CSL hemophilia therapy gets orphan drug status
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP), which can be used for the treatment of Hemophilia B, has been gran...Read more
-
Genetic Technologies Announces Key Managerial Appointment
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Genetic Technologies announced the appointment of Mr. Mark Ostrowski as Senior Vice President Sales and Marketing Molecular Diagnostics. In this role, Mark will be responsible...Read more
-
IMCD acquires Aussie pharma distributor
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: Global distribution firm IMCD Group has acquired Capitol Ingredients Australia, a Sydney headquartered speciality ingredients distributor focused on the nutraceuticals, personal ...Read more
-
Bionomics, CTx advance in growth factor research
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2013
Singapore: Bionomics joint program with the Australian Partner consortium Co-operative Research Centre for Cancer Therapeutics (CTx) has reached a proof of concept milestone in the discover...Read more
-
Ansell Completes Acquisition of Comasec SAS
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Ansell, global leader in protective solutions, has successfully concluded its acquisition of Comasec SAS, having received regulatory approval for the transaction. The deal is va...Read more
-
Commercialisation Australia grants $1 mn to Proteomics
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Aug, 2012
Singapore: Commercialisation Australia has awarded Proteomics International, a life sciences company based in Perth, with $1 million grant to develop its biomarkers for diabetic kidney dise...Read more
